FOSTER CITY (dpa-AFX) – Gilead Sciences Inc. (GILD) on Friday said the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended marketing authorization for Trodelvy a…
Gilead Gets Positive CHMP Opinion For Trodelvy In First-Line Metastatic TNBC
Source: Finanznachrichten.de
Read Full Story →
